🚀 Product Launch Content: Starquin 200
We are pleased to introduce Starquin 200, a clinically trusted formulation of Hydroxychloroquine Sulphate 200 mg, developed to meet the evolving needs in the management of rheumatoid arthritis and systemic lupus erythematosus (SLE).
As a cornerstone in autoimmune disease therapy, Starquin 200 delivers consistent efficacy, excellent tolerability, and long-term disease-modifying benefits—making it an indispensable choice for both clinicians and patients.
🔬 Product Overview
- Generic Name: Hydroxychloroquine Sulphate
- Strength: 200 mg
- Dosage Form: Oral Tablet
- Therapeutic Class: Disease-Modifying Antirheumatic Drug (DMARD)
- Primary Indications:
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Juvenile Idiopathic Arthritis (off-label)
- Mechanism of Action: Modulates immune activity by interfering with lysosomal activity and antigen presentation, reducing autoantibody production and inflammation.
✅ Key Benefits
- Proven Immunomodulatory Action – Slows disease progression and controls symptoms effectively
- Anti-inflammatory Properties – Reduces joint pain, stiffness, and fatigue
- Well-Tolerated Long-Term Therapy – Suitable for chronic use under medical supervision
- Supports Skin and Joint Health – Especially beneficial in cutaneous lupus
- Backed by Global Guidelines – Recommended in multiple rheumatology protocols
👨⚕️ Target Audience
- Doctors & Specialists – Rheumatologists, Internal Medicine, Dermatologists
- Hospitals & Clinics – For inclusion in autoimmune disease treatment protocols
- Patients – Seeking effective, long-term disease management with reduced side effects
🌟 Commitment to Clinical Excellence
Starquin 200 is designed to empower both patients and healthcare professionals with a reliable, research-backed therapeutic solution in autoimmune care. Manufactured to the highest quality standards, Starquin 200 represents commitment to innovation, safety, and patient-centric outcomes.
Starquin 200 – Restoring Balance, Sustaining Relief.
📦 Availability
For detailed prescribing information, clinical study data, or patient support materials, please get in touch with our medical team or visit Starquin 200.
